Por: RTTNews Health October 10, 2023
Biotechnology company Inovio Pharmaceuticals, Inc. () announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.The FDA also advised that the company's previously planned Phase 3 randomized, placebo-controlled... + full article
RTTNews USA Health September 07, 2023
Biotechnology company Inovio Pharmaceuticals, Inc. () announced Thursday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for INO-3107 as a potential treatment for patients with Recurrent Respiratory Papillomatosis (RRP).The... + más
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP | RTTNews
INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis | RTTNews
MarketWatch USA Business April 06, 2023
Much of this is being parked at the Federal Reserve via its overnight reverse repo facility, or “RRP,” where funds can reap returns as high as 4.8% on an annualized basis, according to data from the New York Fed. The concern is that if in money-market funds, they might... + más
'Frustration' fuels Broncos' sideline blowup in loss | ESPN
'Frustration' fuels Denver Broncos' sideline blowup in loss | ABC News
MarketWatch USA Politics April 06, 2023
Orlando Sentinel USA Sports March 25, 2023
Orangewood Christian 11, The Master’s Academy 1 Buzz: Austin Waring threw 5 innings of 1-run ball (0 earned runs) while allowing 4 hits and striking out 8 for Orangewood Christian. He lowered his season ERA to 0.78. Aiden McKee went 3-for-3 with a double, a walk, an RBI and a... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
RTTNews USA Health February 02, 2023
Biotechnology company INOVIO Pharmaceuticals, Inc. () announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.In the trial,... + más
Eye drops recalled after 55 reports of bacterial infection, 1 death in 12 states | ABC News
RTTNews USA Health November 14, 2022
Biopharmaceutical company Protalix BioTherapeutics, Inc. () announced Monday the resubmission on Wednesday of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for PRX-102 (pegunigalsidase alfa) for the treatment of adult patients with Fabry... + más
Valtteri Bottas Is Thriving In Leadership Role With Alfa Romeo | Forbes
Sarepta Submits BLA For SRP-9001 To Treat Ambulant Patients With Duchenne Muscular Dystrophy | RTTNews
RTTNews USA Health October 13, 2022
Biotechnology company Inovio Pharmaceuticals Inc. () announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.In the first cohort... + más
Surge of respiratory illnesses in children straining some hospitals' capacity | ABC News
NKorea launches 2 missiles toward sea after US-SKorea drills | ABC News
About iurex | Privacy Policy | Disclaimer |